NSEShareholders meeting3d ago · 18 Sept 2026, 05:20 pm
Shareholders meeting
Jagsonpal Pharmaceuticals Limited · JAGSNPHARM
✦ AI SummaryResults
Jagsonpal Pharmaceuticals Limited held its 47th Annual General Meeting (AGM) on September 18, 2026, through video conferencing. The meeting adopted audited financial statements for FY 2026, declared a dividend, and appointed a new director. The company also ratified the remuneration of its cost auditors and approved the appointment of an independent director.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jagsonpal Pharmaceuticals Limited has informed the Exchange about Shareholders meeting
Attachments (1)
📄pdf
Download →
JAGSNPHARM_18092026171744_AGMProceedings2025-26.pdf
View document text
September 18, 2026
The Department of Corporate Services- Listing The Department of Corporate Services- Listing
BSE Ltd, National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G,
Dalal Street Bandra Kurla Complex,
Mumbai-400 001 Bandra (E) Mumbai – 400 051
Scrip Code: 507789 Symbol: JAGSNPHARM
Subject: Proceedings of the 47th Annual General Meeting (‘AGM’) of the Company and disclosure under SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir/ Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing
Regulations’) read with Para A of Part A of Schedule III of the Listing Regulations, please find enclosed herewith
summary of the proceedings of the 47th AGM of the Company held through Video Conference/ Other Audio Visual
Means (VC/OAVM) on Friday, September 18, 2026 (commenced at 3:30 p.m. and concluded at 4:04 p.m.).
The detailed results of e-Voting (both for remote e-Voting and Voting at AGM) along with Scrutinizer‘s Report shall
be intimated separately.
We request you to take the above on record.
Thanking you,
Yours faithfully,
For Jagsonpal Pharmaceuticals Limited
Pratham Rawal
Company Secretary & Compliance Officer
Encl.: As above
Summary of the Proceedings of the 47th Annual General Meeting of Jagsonpal Pharmaceuticals Limited
through Video Conferencing (‘VC’)/Other Audio Video Means (‘OVAM’)
The 47th Annual General Meeting (‘AGM’) of the members of Jagsonpal Pharmaceuticals Limited (‘the Company’) was
held on Friday, September 18, 2026 at 03:30 p.m. (IST) through Video Conferencing/Other Audio Visual Means
(‘VC/OAVM’) in accordance with the applicable provisions of Companies Act, 2013 read with the Rules, Circulars
issued thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (Listing Regulations).
In the absence of Mr. Harsha Raghavan, Non-Executive Director and Chairperson of the Board, Mr. Manish Gupta,
Managing Director of the Company, was unanimously elected as the Chairperson of the meeting to conduct the
proceedings of the AGM.
The Requisite quorum being present, the Chairperson called the meeting to be in order and welcomed all the members.
The Notice of AGM and Auditor's Report were taken as read.
The Chairperson made a presentation the shareholders on the operational and financial performance for FY 26 followed
by a Q&A with the attendees wherein the Managing Director, CFO and COO provided clarification to the queries raised.
Mr. Pratham Rawal, Company Secretary apprised the members that in Compliance with provision of Section 108 of the
Companies Act, 2013, Rule 20 of the Companies (Management and Administration) Rules 2014, as amended and
applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had
provided members the facility to cast vote electronically through remote e-Voting (which started at 09.00 A.M. on
Monday, September 14, 2026, and concluded at 05:00 P.M. on Thursday, September 17, 2026 electronically on all the
resolutions as set forth in the AGM Notice. Further, the members who were present at the meeting and had not cast their
vote by remote e-voting were allowed to cast their votes at the AGM. Following items of business were transacted at the
meeting:
Item No. Resolution description Type of resolution
Ordinary Business
1 Adoption of Audited Financial Statements for the Financial Year Ordinary
ended March 31, 2026
2 Declaration of Dividend for the Financial Year ended March 31, Ordinary
2026
3 To appoint a director in place of Mr. Prithipal Singh Kochar, Non- Ordinary
Executive Director (DIN No. 01052194) who retires by rotation
and being eligible, offers himself for reappointment
Special Business
4 Ratification of remuneration payable to Kirit Mehta & CO LLP, Ordinary
Cost Accountants, Cost Auditors of the Company for the Financial
Year ending March 31, 2027
5 Approve Appointment of Mr. Anil Kumar Matai (DIN: 03122685) Special
as an Independent Director of the Company
Further, the members were informed that Mr. Ayush Khandelwal, M/s Ayush Khandelwal & Associates., Company
Secretaries was appointed as Scrutinizer to scrutinize the remote e-voting and e-voting at AGM and the voting results
on resolutions will be announced on receipt of Consolidated Scrutiniser's Report within 2 working days from the
conclusion of the meeting and simultaneously be disseminated to the stock exchanges and also be placed on the website
of the Company and National Securities Depository Limited (NSDL).
The Chairperson then thanked the members present at the meeting and declared the meeting closed at 4:04 P.M.
The Chairperson concluded the meeting with a vote of thanks.
Yours faithfully,
For Jagsonpal Pharmaceuticals Limited
Pratham Rawal
Company Secretary & Compliance Officer